A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4515 (2006.01) A61K 31/00 (2006.01) A61K 45/00 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2712800
This application describes compositions of receptor inhibitors, including antipsychotic agents, for example haloperidol, and methods of use for alleviating clinical depression, improving cognition and/or treating other syndromes, conditions or diseases for which anti-depressant agents are prescribed. Furthermore, this application describes compositions and methods to induce supersensitivity in dopamine D2 and other receptors involved in depression and/or cognition as a means of alleviating clinical depression or improving cognition.
L'invention concerne des compositions d'inhibiteurs de récepteurs, y compris des agents antipsychotiques tels que l'halopéridol, par exemple, et des procédés d'utilisation de celles-ci en vue de soulager la dépression clinique, d'améliorer les processus cognitifs et/ou de traiter d'autres syndromes, états pathologiques ou maladies pour lesquels des agents antidépresseurs sont prescrits. De plus, l'invention concerne des compositions et des procédés visant à induire une hyersensibilité aux récepteurs dopaminergiques D2 et à d'autres récepteurs impliqués dans la dépression et/ou les processus cognitifs, afin de soulager la dépression clinique ou d'améliorer les processus cognitifs.
Seeman Philip
Toleikis Philip M.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Clera Inc.
LandOfFree
Compositions and methods for alleviating depression or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for alleviating depression or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for alleviating depression or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2031361